reference/1768435

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/1768435

Outgoing Links

Predicate	Object
contentType	Journal Article\|Research Support, Non-U.S. Gov't
endingPage	2484
issn	0223-5234
issueIdentifier	6
pageRange	2477-2484
publicationName	European Journal of Medicinal Chemistry
startingPage	2477
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_647e94c6c1ddede3c4f5c2a153c50845 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_53df71003979191dbf7bf509c37a8db3 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_b037063e37cf23d8139a65083019c55a http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_5b5963eb6d98657850c3e41ca1fe60d1 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_1574fd8fe834fd1e225901dbc941f89e
bibliographicCitation	Dong Z, Tan R, Cao J, Yang Y, Kong C, Du J, Zhu S, Zhang Y, Lu J, Huang B, Liu S. Discovery of polyoxometalate-based HDAC inhibitors with profound anticancer activity in vitro and in vivo. European Journal of Medicinal Chemistry. 2011 Jun;46(6):2477–84. doi: 10.1016/j.ejmech.2011.03.036.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6c073da68708dc8442b161b4af7de6f8 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5f7b8759c6fd560b22e9f0103520d7ed http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4f414fa6845f7d062ddf26dc0d89d635 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3e61bab9d561cb73b146dd1ab35f8e66 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7aca161862225801b1a8bb691fcb08f8 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8cb0169753f048e04d215638e87193f6 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_645bd5c7c983695f685c121707d165d3 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e7fe0ffd8a2399d1f2c63a26118fc99b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5538cb10d94d53b48fed486e5102de7c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_89baf9bc30b61b3ef80a784965dd4543 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7b343048ea63c3b1812af08fe3537acb
date	201106
identifier	https://pubmed.ncbi.nlm.nih.gov/21481498 https://doi.org/10.1016/j.ejmech.2011.03.036
isPartOf	https://portal.issn.org/resource/ISSN/0223-5234 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/21651
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	Discovery of polyoxometalate-based HDAC inhibitors with profound anticancer activity in vitro and in vivo
discusses	http://id.nlm.nih.gov/mesh/M0527853 http://id.nlm.nih.gov/mesh/M0001483 http://id.nlm.nih.gov/mesh/M0027141 http://id.nlm.nih.gov/mesh/M0267908
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D000970Q000494 http://id.nlm.nih.gov/mesh/D017973Q000494 http://id.nlm.nih.gov/mesh/D055808 http://id.nlm.nih.gov/mesh/D056572Q000494
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D000970Q000737 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D008958 http://id.nlm.nih.gov/mesh/D013329 http://id.nlm.nih.gov/mesh/D017973Q000138 http://id.nlm.nih.gov/mesh/D000970Q000138 http://id.nlm.nih.gov/mesh/D000818 http://id.nlm.nih.gov/mesh/D004789Q000187 http://id.nlm.nih.gov/mesh/D049109Q000187 http://id.nlm.nih.gov/mesh/D002460 http://id.nlm.nih.gov/mesh/D056572Q000138 http://id.nlm.nih.gov/mesh/D017973Q000737 http://id.nlm.nih.gov/mesh/D004354 http://id.nlm.nih.gov/mesh/D002470Q000187 http://id.nlm.nih.gov/mesh/D056572Q000737 http://id.nlm.nih.gov/mesh/D018360 http://id.nlm.nih.gov/mesh/D004305 http://id.nlm.nih.gov/mesh/D051379
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7998 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5352426 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_daa31e5601dc8e8d613ec227a938992f http://rdf.ncbi.nlm.nih.gov/pubchem/protein/EC_3.5.1.98 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607

Total number of triples: 64.